TipRanks
Firebrick Pharma Limited (AU:FRE)
ASX:FRE
Australian Market
FRE
Firebrick Pharma Limited
RESEARCH TOOLSreports
Want to see AU:FRE full AI Analyst Report?

Firebrick Pharma Limited (FRE) Ratios

8 Followers

Firebrick Pharma Limited Ratios

AU:FRE's free cash flow for Q4 2026 was AU$-15.91. For the 2026 fiscal year, AU:FRE's free cash flow was decreased by AU$ and operating cash flow was AU$-42.24. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 3.85 3.85 5.47 7.19 5.11
Quick Ratio
 3.10 3.10 4.75 6.36 5.11
Cash Ratio
 2.74 2.74 3.62 2.83 4.65
Solvency Ratio
 -6.33 -6.33 -9.68 -4.02 -13.41
Operating Cash Flow Ratio
 -5.39 -5.39 -6.56 -8.06 -11.42
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
AU$ 1.38MAU$ 1.38MAU$ 1.21MAU$ 1.80MAU$ 2.08M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.29 1.29 1.17 1.14 1.20
Debt Service Coverage Ratio
 0.00 0.00 0.00 1.56K 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 -3.90K 0.00
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.00 0.00 0.00 <0.01 0.00
Net Debt to EBITDA
 0.43 0.43 0.34 0.71 0.35
Profitability Margins
Gross Profit Margin
-1063.73%-977.06%35.72%-156.88%100.00%
EBIT Margin
-2925.61%-2925.61%-976.65%-8090.19%-822143.61%
EBITDA Margin
-2921.29%-2921.29%-973.71%-8040.75%-820996.75%
Operating Profit Margin
-2925.61%-2925.61%-976.65%-27045.99%-826956.63%
Pretax Profit Margin
-2916.45%-2916.30%-897.83%-8097.12%-822143.61%
Net Profit Margin
-2889.11%-2889.11%-897.83%-8097.12%-819526.75%
Continuous Operations Profit Margin
-2889.11%-2889.11%-897.83%-8097.12%-819526.75%
Net Income Per EBT
99.06%99.07%100.00%100.00%99.68%
EBT Per EBIT
99.69%99.68%91.93%29.94%99.42%
Return on Assets (ROA)
-141.49%-141.49%-144.14%-48.87%-228.07%
Return on Equity (ROE)
-169.20%-182.12%-169.27%-55.59%-274.72%
Return on Capital Employed (ROCE)
-184.42%-184.42%-184.13%-185.68%-277.21%
Return on Invested Capital (ROIC)
-182.69%-182.70%-168.60%246.32%-276.33%
Return on Tangible Assets
-141.49%-141.49%-144.14%-48.87%-228.07%
Earnings Yield
-40.21%-33.45%-20.21%-12.39%-25.80%
Efficiency Ratios
Receivables Turnover
 2.12 2.12 1.14 0.02 <0.01
Payables Turnover
 6.10 5.65 1.67 0.54 0.00
Inventory Turnover
 3.40 3.14 0.97 0.16 0.00
Fixed Asset Turnover
 0.93 0.93 3.10 0.54 0.02
Asset Turnover
 0.05 0.05 0.16 <0.01 <0.01
Working Capital Turnover Ratio
 0.07 0.08 0.19 <0.01 <0.01
Cash Conversion Cycle
 220.14 223.98 477.43 25.57K 60.41K
Days of Sales Outstanding
 172.53 172.53 320.70 23.90K 60.41K
Days of Inventory Outstanding
 107.46 116.10 375.40 2.35K 0.00
Days of Payables Outstanding
 59.84 64.65 218.68 674.17 0.00
Operating Cycle
 279.98 288.63 696.10 26.25K 60.41K
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 -0.01 >-0.01 -0.01 -0.03
Free Cash Flow Per Share
 >-0.01 -0.01 >-0.01 -0.01 -0.03
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.05 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -867.93K -520.76K -21.44 -17.50K -3.58K
Capital Expenditure Coverage Ratio
 -867.93K -520.76K -21.44 -17.50K -3.58K
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 -24.56 -24.56 -6.06 -161.47 -6.97K
Free Cash Flow Yield
-37.54%-28.44%-14.28%-24.71%-21.94%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -2.42 -3.00 -4.96 -8.07 -3.88
Price-to-Sales (P/S) Ratio
 65.42 86.36 44.43 653.39 31.76K
Price-to-Book (P/B) Ratio
 4.53 5.44 8.38 4.49 10.65
Price-to-Free Cash Flow (P/FCF) Ratio
 -2.66 -3.52 -7.00 -4.05 -4.56
Price-to-Operating Cash Flow Ratio
 -2.93 -3.52 -7.33 -4.05 -4.56
Price-to-Earnings Growth (PEG) Ratio
 -4.25 0.75 -0.06 0.10 -0.05
Price-to-Fair Value
 4.53 5.44 8.38 4.49 10.65
Enterprise Value Multiple
 -1.81 -2.53 -4.22 -7.42 -3.52
Enterprise Value
 5.61M 7.84M 12.05M 8.66M 24.01M
EV to EBITDA
 -1.81 -2.53 -4.22 -7.42 -3.52
EV to Sales
 52.95 73.90 41.08 596.60 28.93K
EV to Free Cash Flow
 -2.16 -3.01 -6.47 -3.69 -4.15
EV to Operating Cash Flow
 -2.16 -3.01 -6.77 -3.69 -4.15
Tangible Book Value Per Share
 <0.01 <0.01 <0.01 0.01 0.01
Shareholders’ Equity Per Share
 <0.01 <0.01 <0.01 0.01 0.01
Tax and Other Ratios
Effective Tax Rate
 <0.01 <0.01 0.08 2.33 <0.01
Revenue Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
 -0.01 -0.01 -0.01 >-0.01 -0.04
Tax Burden
 0.99 0.99 1.00 1.00 1.00
Interest Burden
 1.00 1.00 0.92 1.00 1.00
Research & Development to Revenue
 5.18 5.18 2.51 131.19 4.93K
SG&A to Revenue
 13.44 14.31 3.54 15.00 352.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.21 >-0.01 2.54
Income Quality
 0.85 0.85 0.68 1.99 0.85
Currency in AUD